"ქართულ-ფრანგული ერთობლივი ჰეპატოლოგიური კლინიკა "ჰეპა" გთავაზობთ ღვიძლის ინფექციური და არაინფექციური დაავადებების დიაგნოსტიკას და მკურნალობას უახლესი მაღალტექნოლოგიური მეთოდებით. კლინიკას ხელმძღვანელობენ პროფესორი თენგიზ ცერცვაძე"

During the past decade, Hepatology Clinic Hepa conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Hepatology Clinic Hepa" are "Hepatitis C, Chronic" (1 trials) and "Postmenopausal Osteoporosis" (1 trials). Many other conditions were trialed in "Hepatology Clinic Hepa" in a lesser frequency.

Most popular intervention types in "Hepatology Clinic Hepa" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "FKS518" (1 trials), "Pegylated Interferon Alfa-2a" (1 trials), "Ribavirin" (1 trials) and "US-licensed Prolia" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hepatology Clinic Hepa" are 1 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Hepatology Clinic Hepa". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Hepatology Clinic Hepa, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hepatology Clinic Hepa, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".